We provide you with 20 years of free, institutional-grade data for MRSN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MRSN. Explore the full financial landscape of MRSN stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-02-28 | 1442836 | MRSN | 10-K | Url |
| 2023-11-07 | 1442836 | MRSN | 10-Q | Url |
| 2023-08-08 | 1442836 | MRSN | 10-Q | Url |
| 2023-05-09 | 1442836 | MRSN | 10-Q | Url |
| 2023-02-28 | 1442836 | MRSN | 10-K | Url |
| 2022-11-07 | 1442836 | MRSN | 10-Q | Url |
| 2022-08-08 | 1442836 | MRSN | 10-Q | Url |
| 2022-05-09 | 1442836 | MRSN | 10-Q | Url |
| 2022-02-28 | 1442836 | MRSN | 10-K | Url |
| 2021-11-09 | 1442836 | MRSN | 10-Q | Url |
| 2021-08-06 | 1442836 | MRSN | 10-Q | Url |
| 2021-05-10 | 1442836 | MRSN | 10-Q | Url |
| 2021-02-26 | 1442836 | MRSN | 10-K | Url |
| 2020-11-09 | 1442836 | MRSN | 10-Q | Url |
| 2020-08-07 | 1442836 | MRSN | 10-Q | Url |
| 2020-05-08 | 1442836 | MRSN | 10-Q | Url |
| 2020-02-28 | 1442836 | MRSN | 10-K | Url |
| 2019-11-06 | 1442836 | MRSN | 10-Q | Url |
| 2019-08-08 | 1442836 | MRSN | 10-Q | Url |
| 2019-05-09 | 1442836 | MRSN | 10-Q | Url |
| 2019-03-08 | 1442836 | MRSN | 10-K | Url |
| 2018-11-13 | 1442836 | MRSN | 10-Q | Url |
| 2018-08-14 | 1442836 | MRSN | 10-Q | Url |
| 2018-05-15 | 1442836 | MRSN | 10-Q | Url |
| 2018-03-28 | 1442836 | MRSN | 10-K | Url |
| 2017-11-13 | 1442836 | MRSN | 10-Q | Url |
| 2017-08-11 | 1442836 | MRSN | 10-Q | Url |
| 2017-06-01 | 1442836 | MRSN | S-1 | Url |
Mersana Therapeutics, Inc(NASDAQ:MRSN) 
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development of antibody drug conjugates (ADC) for cancer patients with unmet need. The company develops XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients w...
Website: http://www.mersana.com
Founded: 2001
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MRSN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.